SOLV
Solventum CorporationStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.02% · Russell 1000 0.02% · Russell 3000 0.02% · US Stock Market 0.02% · MSCI World 0.01% · MSCI ACWI 0.01%$88.84+1.50%
as of market close, Sep 18, 2026
☾ AH — —
SOLV — Solventum Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
50.055.060.065.070.075.080.085.090.0010.0M$88.84—202420252026
2026-09-18
Price$88.84
MA20$88.37
MA50$81.13
Vol2.3M
Key stats
Price data
- Price
- $88.84
- Change YTD
- +12.12%
- Next earnings
- Nov 5, 2026
- Market cap
- 15.1B
- Enterprise value
- 20.2B
- Shares outstanding
- 170.2M
- 52W low
- $62.38
- 52W high
- $94.16
- From 52W high
- -5.65%
- From 52W low
- +42.42%
- 52W range
- 83%
Volume
- Rel volume
- 2.28×
- 30D volume
- 1M
- 30D $ vol
- 90.4M
Fundamentals
- Sales (ttm)
- 8.3B
- Sales/share
- $48.82
- EPS (ttm)
- $8.19
- FCF (ttm)
- -118M
- FCF/share
- -$0.69
- Book value/share
- $28.20
- Net margin
- 17.26%
- ROE
- 29.88%
- ROA
- 10.07%
- Debt / equity
- 0.95×
- Current ratio
- 1.02
Growth (CAGR, ttm) · 10Y
- Sales
- -0.93%+0.63%n/an/a
- Net income
- +277.71%+1.89%n/an/a
- Shares
- -1.83%-0.48%n/an/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +276.85%+1.49%n/an/a
- Sales/share
- +0.91%+1.04%n/an/a
- Book value/share
- +34.16%-25.39%n/an/a
- Price
- +19.47%+4.32%n/an/a
- Total return
- +19.47%+4.32%n/an/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 10.8×
- Fwd P/E
- 12.1×
- P/S (ttm)
- 1.8×
- P/B (mrq)
- 3.2×
- EV/EBITDA (fy)
- 7.9×
- EV/Sales (ttm)
- 2.4×
- FCF yield (ttm)
- -0.78%
- Buyback yield (realized, 1y)
- 1.83%
- Shareholder yield (realized, 1y)
- 1.83%
- Buyback yield (cash, ttm)
- 2.35%
- Shareholder yield (cash, ttm)
- 2.35%
Performance · price return · as of 2026-09-18
1D
+1.50%
5D
+1.59%
1M
+1.59%
3M
+17.78%
YTD
+12.12%
1Y
+19.46%
5Y
—
Financial statements
Open full SOLV financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -5.94% | +0.04% |
| JNJ | Johnson & Johnson | -0.41% | -0.09% |
| ABBV | AbbVie Inc. | +1.95% | -0.02% |
| MRK | Merck & Co. Inc. | +8.66% | -0.19% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -4.32% | +0.45% |
| TMO | Thermo Fisher Scientific Inc. | +10.60% | -1.04% |
| AMGN | Amgen Inc. | -9.32% | +1.55% |
| GILD | Gilead Sciences Inc. | +4.65% | -0.52% |
Solventum Corporation (SOLV) trades at $88.84 with a live price and an interactive chart covering 2+ years of daily price history, plus key valuation metrics. ChartRow also publishes SOLV’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full SOLV financial statements →
